News
What changed for people on GLP-1 treatment
Medicines (approvals, safety, access), nutrition and exercise. Only what changes something for you, with the date and the source on every item. No miracle cures, no promises.
Last checked: 16 November 2026
Sources: EMA · FDA · MHRA · medical journals · manufacturers
How we check an item →November 2026
9 NovExerciseStudy
Strength training keeps muscle and builds strength during treatment
For you: three strength sessions a week. In the study, people who trained got stronger while losing about the same weight.
Source: University of Western Australia — news release on the T-REx study (Green et al., Nature Medicine, 2026)Mounjaro
October 2026
26 OctNutritionStudy
Protein in the first months of treatment: most people eat less than they think
For you: check your target in the protein calculator. It is easy to fix with ordinary food.
Source: Ramel A. — Dietary intake and weight loss in obese adults during GLP-1 receptor agonist treatment, European Journal of Public Health, 2026;36(Suppl 5)
September 2026
29 SepMedicinesStudy
Research moves forward: the main retatrutide trial is published
For you: it is still an investigational medicine. The treatment you have now is the one to follow.
Source: New England Journal of Medicine, 29 September 2026 (Jastreboff et al., TRIUMPH-1) — reported by Scientific American · Eli Lilly — TRIUMPH-2 and TRIUMPH-3 results, 23 July 2026 · Reuters via FOX 9 — Eli Lilly offers retatrutide to some patients before FDA approval, 7 August 2026